Product Information

FT IBUPROFEN IB 100 MG CHEW TB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1526 per EA under NDC 70677114501. Its NADAC has been published 137 times since Jan 10, 2024.

FDA first approved this application on Jan 16, 2004.

The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FT IBUPROFEN IB 100 MG CHEW TB

Ibuprofen
$0.1526per EA
High Outlier
OTC

Strength

100 mg/1

NDC

70677114501

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA076359

FDA Approved

1/16/2004

On Market Since

10/27/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT IBUPROFEN IB 100 MG CHEW TB has been published 137 times since Jan 10, 2024, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1526 per EA
All-time high$0.1554 (May 13, 2026)
All-time low$0.1318 (Apr 17, 2024)
52-week high$0.1554
52-week low$0.1393
Median price$0.1408
Average price$0.1429
Largest weekly change+9.0% (May 22, 2024)
Weeks tracked137
Tracking sinceJan 10, 2024

Price History

1W

+0.4%

1M

0.0%

3M

-0.9%

6M

+1.3%

1Y

+8.4%

3Y

N/A

5Y

N/A

All

+9.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT IBUPROFEN IB 100 MG CHEW TB?

The current National Average Drug Acquisition Cost (NADAC) for FT IBUPROFEN IB 100 MG CHEW TB, manufactured by Strategic Sourcing Services LLC, is $0.1526 per EA (NDC 70677114501), effective Aug 19, 2026.

How has the price of FT IBUPROFEN IB 100 MG CHEW TB changed over time?

Over the history we have for it, the NADAC for FT IBUPROFEN IB 100 MG CHEW TB has risen 9.5%. It has been tracked across 137 weekly CMS publications since Jan 10, 2024.

What are the highest and lowest recorded NADAC prices for FT IBUPROFEN IB 100 MG CHEW TB?

Since Jan 10, 2024, the NADAC for FT IBUPROFEN IB 100 MG CHEW TB has ranged from a low of $0.1318 (Apr 17, 2024) to a high of $0.1554 (May 13, 2026), with a median of $0.1408 per EA.

Are there cheaper alternatives to FT IBUPROFEN IB 100 MG CHEW TB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT IBUPROFEN IB 100 MG CHEW TB in a comparable dosage form, but none are currently priced below it.

Who manufactures FT IBUPROFEN IB 100 MG CHEW TB?

FT IBUPROFEN IB 100 MG CHEW TB (NDC 70677114501) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.